GOVX 8-K 2026-11-06

GeoVax Labs, Inc. (GOVX) 8-K dated 2026-11-06 — accession 0001437749-26-035579.

GeoVax Labs, Inc. (GOVX) is a biotechnology company listed on US.

GeoVax Labs, Inc. filed a 8-K on 2026-11-06. Accession 0001437749-26-035579.

This 8-K covers: Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GOVX revenue for 2025-12-31 was $2.5M. Net income was -$21.5M. Revenue was down 37.1% from 2024-12-31 to 2025-12-31. GOVX currently screens at market cap $10.6M.

Not investment advice. The GOVX SEC hub lists recent forms. The stock page is the research view.